{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:19:03Z","timestamp":1793272743011,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/md.0b013e3181af4518","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T03:22:49Z","timestamp":1247023369000},"page":"227-235","source":"Crossref","is-referenced-by-count":213,"title":["Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis"],"prefix":"10.1097","volume":"88","author":[{"given":"Miguel A.","family":"Gonzalez-Gay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas R.","family":"Vazquez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Gomez-Acebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robustiano","family":"Pego-Reigosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Lopez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde C.","family":"Vazquez-Tri\u00f1anes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Miranda-Filloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Dierssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gonzalez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210226","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis.","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"R2-6-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-8-5","article-title":"Sancho A; \"ISISCOG Study Group,\" Pera G. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study.","volume":"8","author":"Alzamora","year":"2008","journal-title":"BMC Neurol"},{"key":"R4-6-20210226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","article-title":"High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.","volume":"48","author":"Berger","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R5-6-20210226","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis.","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"R6-6-20210226","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0889-857X(21)00214-3","article-title":"Neurologic aspects of giant cell (temporal) arteritis.","volume":"19","author":"Caselli","year":"1993","journal-title":"Rheum Dis Clin North Am"},{"key":"R7-6-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R8-6-20210226","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000030185.67510.C0","article-title":"Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis.","volume":"106","author":"Cid","year":"2002","journal-title":"Circulation"},{"key":"R9-6-20210226","first-page":"1181","article-title":"Glucocorticoids in the management of vasculitis-a double edged sword?","volume":"15","author":"Conn","year":"1988","journal-title":"J Rheumatol"},{"key":"R10-6-20210226","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.semarthrit.2003.09.007","article-title":"Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.","volume":"33","author":"Gonzalez-Gay","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R11-6-20210226","first-page":"277","article-title":"Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients.","volume":"19","author":"Gonzalez-Gay","year":"1992","journal-title":"J Rheumatol"},{"key":"R12-6-20210226","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sarh.2002.50025","article-title":"Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.","volume":"33","author":"Gonzalez-Gay","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"R13-6-20210226","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R14-6-20210226","first-page":"193","article-title":"Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol. 1997;24:2171-2176.","volume":"25","author":"Gonzalez-Gay","year":"1998","journal-title":"Erratum in: J Rheumatol"},{"key":"R15-6-20210226","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R16-6-20210226","first-page":"520","article-title":"Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern Europe.","volume":"31","author":"Gonzalez-Gay","year":"2004","journal-title":"J Rheumatol"},{"key":"R17-6-20210226","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","article-title":"Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiological aspects.","volume":"78","author":"Gonzalez-Gay","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"R18-6-20210226","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","article-title":"Epidemiology of the vasculitides.","volume":"27","author":"Gonzalez-Gay","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"R19-6-20210226","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"R20-6-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients.","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R21-6-20210226","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study.","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R22-6-20210226","first-page":"1750","article-title":"Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.","volume":"25","author":"Gonzalez-Gay","year":"1998","journal-title":"J Rheumatol"},{"key":"R23-6-20210226","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a ten-year study.","volume":"26","author":"Gonzalez-Gay","year":"1999","journal-title":"J Rheumatol"},{"key":"R24-6-20210226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients.","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R25-6-20210226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study.","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"R26-6-20210226","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R28-6-20210226","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.23114","article-title":"Atherosclerosis in patients with biopsy-proven giant cell arteritis.","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R29-6-20210226","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.282.6260.269","article-title":"Prognosis in giant-cell arteritis.","volume":"282","author":"Graham","year":"1981","journal-title":"Br Med J"},{"key":"R30-6-20210226","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","article-title":"Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls.","volume":"40","author":"Gran","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R31-6-20210226","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.287.22.2996","article-title":"Temporal arteritis: a cough, toothache, and tongue infarction.","volume":"287","author":"Hellmann","year":"2002","journal-title":"JAMA"},{"key":"R32-6-20210226","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R33-6-20210226","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002281-200201000-00002","article-title":"Giant cell arteritis.","volume":"14","author":"Levine","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"R34-6-20210226","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2007.10.014","article-title":"The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.","volume":"38","author":"Lopez-Diaz","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"R35-6-20210226","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort.","volume":"100","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"R36-6-20210226","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R37-6-20210226","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.299.6698.549","article-title":"Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy.","volume":"299","author":"Nordborg","year":"1989","journal-title":"BMJ"},{"key":"R38-6-20210226","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R40-6-20210226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(90)90100-R","article-title":"Neurologic manifestations of giant cell arteritis.","volume":"89","author":"Reich","year":"1990","journal-title":"Am J Med"},{"key":"R41-6-20210226","first-page":"1737","article-title":"A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.","volume":"32","author":"Rueda","year":"2005","journal-title":"J Rheumatol"},{"key":"R42-6-20210226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis.","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"R43-6-20210226","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","article-title":"Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.","volume":"48","author":"Salvarani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R44-6-20210226","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.STR.15.5.790","article-title":"The natural history of hemispheric and brainstem infarction in Rochester, Minnesota.","volume":"15","author":"Turney","year":"1984","journal-title":"Stroke"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181af4518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:52:19Z","timestamp":1786038739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200907000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181af4518","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}